Hypertension during pregnancy could lead to increased FNAIT risk
A recent study showed that pregnant mothers with hypertension or preeclampsia may be at a higher risk of developing FNAIT.
A recent study showed that pregnant mothers with hypertension or preeclampsia may be at a higher risk of developing FNAIT.
Evaluating plasma thrombopoietin (TPO) levels among neonates with low platelet counts has been shown to speed up diagnosis and treatment.
A recently published case study showed that single-gene disorders may be associated with the occurrence of fetal intracranial hemorrhage.
A recent study found that the presence of certain antibodies may put patients at a higher risk of recurrent miscarriages.
A recent study showed that those treated with IVIG may be at a greater risk of complications if they have certain medical conditions.
The use of antenatal anti–human platelet antigen-1a (HPA-1a) screening for FNAIT has shown to be cost effective in Europe.
A recent educational case report described a case of FNAIT in which the mother did not receive adequate prenatal care and testing.
A recent study showed a potential FNAIT treatment was successful in mice.
A recent study found there was no association with low maternal platelet count with the eventual diagnosis of neonatal thrombocytopenia.
A recent case report describes a case of suspected FNAIT in Nigeria that ultimately resulted in the death of the infant.